Bacterial Adaptation during Chronic Respiratory Infections
暂无分享,去创建一个
[1] S. Lewandowsky. PLOS ONE 2013 , 2015 .
[2] D. Speert,et al. Swimming Motility in a Longitudinal Collection of Clinical Isolates of Burkholderia cepacia Complex Bacteria from People with Cystic Fibrosis , 2014, PloS one.
[3] J. Curtis,et al. Cell-associated bacteria in the human lung microbiome , 2014, Microbiome.
[4] S. Molin,et al. Within-Host Evolution of Pseudomonas aeruginosa Reveals Adaptation toward Iron Acquisition from Hemoglobin , 2014, mBio.
[5] I. Sá-Correia,et al. Burkholderia dolosa phenotypic variation during the decline in lung function of a cystic fibrosis patient during 5.5 years of chronic colonization. , 2014, Journal of medical microbiology.
[6] A. Griffin,et al. Loss of Social Behaviours in Populations of Pseudomonas aeruginosa Infecting Lungs of Patients with Cystic Fibrosis , 2014, PloS one.
[7] Roy Kishony,et al. Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures , 2013, Nature Genetics.
[8] S. McClean,et al. Proteomic Profiling of Burkholderia cenocepacia Clonal Isolates with Different Virulence Potential Retrieved from a Cystic Fibrosis Patient during Chronic Lung Infection , 2013, PloS one.
[9] E. Marcotte,et al. Pseudomonas aeruginosa Enhances Production of a Non-Alginate Exopolysaccharide during Long-Term Colonization of the Cystic Fibrosis Lung , 2013, PloS one.
[10] Alexandro Rodríguez-Rojas,et al. Antibiotics and antibiotic resistance: a bitter fight against evolution. , 2013, International journal of medical microbiology : IJMM.
[11] H. Dienemann,et al. Analysis of the Airway Microbiota of Healthy Individuals and Patients with Chronic Obstructive Pulmonary Disease by T-RFLP and Clone Sequencing , 2013, PloS one.
[12] J. Harris,et al. Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations , 2013, PloS one.
[13] M. Surette,et al. Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient , 2013, PloS one.
[14] B. Berwin,et al. Flagellar Motility Is a Key Determinant of the Magnitude of the Inflammasome Response to Pseudomonas aeruginosa , 2013, Infection and Immunity.
[15] L. Amaral,et al. Mechanisms of Resistance in Bacteria: An Evolutionary Approach , 2013, The open microbiology journal.
[16] T. Coenye,et al. Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems , 2013, PloS one.
[17] G. Rogers,et al. Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[18] J. Vazquez,et al. Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa , 2014, BMC Microbiology.
[19] V. Cooper,et al. Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections , 2012, Proceedings of the National Academy of Sciences.
[20] Anders Folkesson,et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective , 2012, Nature Reviews Microbiology.
[21] S. McClean,et al. Immunoproteomics: The Key to Discovery of New Vaccine Antigens Against Bacterial Respiratory Infections , 2012, Current protein & peptide science.
[22] Jenny Renaut,et al. Gel-Based and Gel-Free Quantitative Proteomics Approaches at a Glance , 2012, International journal of plant genomics.
[23] V. Young,et al. The microbiome of the lung. , 2012, Translational research : the journal of laboratory and clinical medicine.
[24] S. McClean. Eight stranded -Barrel and Related Outer Membrane Proteins: Role in Bacterial Pathogenesis , 2017 .
[25] W. Morgan,et al. Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[26] Sam P. Brown,et al. Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control , 2012, Trends in microbiology.
[27] S. Leroy,et al. The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management , 2012, PloS one.
[28] G. Khanbabaee,et al. A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients. , 2012, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[29] S. McClean,et al. Bacterial host interactions in cystic fibrosis. , 2012, Current opinion in microbiology.
[30] I. Sá-Correia,et al. Genomic Expression Analysis Reveals Strategies of Burkholderia cenocepacia to Adapt to Cystic Fibrosis Patients' Airways and Antimicrobial Therapy , 2011, PloS one.
[31] J. Becker,et al. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence. , 2011, Microbiology.
[32] Kyle Bittinger,et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. , 2011, American journal of respiratory and critical care medicine.
[33] Deborah M Anderson,et al. Host Defense and the Airway Epithelium: Frontline Responses That Protect against Bacterial Invasion and Pneumonia , 2011, Journal of pathogens.
[34] K. Templeton,et al. Adaptive Evolution of Staphylococcus aureus during Chronic Endobronchial Infection of a Cystic Fibrosis Patient , 2011, PloS one.
[35] C. Goss,et al. Review: Staphylococcus aureus and MRSA in cystic fibrosis. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[36] Lars Jelsbak,et al. Bacterial adaptation during chronic infection revealed by independent component analysis of transcriptomic data , 2011, BMC Microbiology.
[37] P. Sokol,et al. Burkholderia cenocepacia ShvR-Regulated Genes That Influence Colony Morphology, Biofilm Formation, and Virulence , 2011, Infection and Immunity.
[38] S. Nseir,et al. Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model , 2011, Critical care.
[39] Tao Liu,et al. Liquid Chromatography-Mass Spectrometry-based Quantitative Proteomics* , 2011, The Journal of Biological Chemistry.
[40] Carla C. C. R. de Carvalho,et al. Burkholderia cenocepacia Phenotypic Clonal Variation during a 3.5-Year Colonization in the Lungs of a Cystic Fibrosis Patient , 2011, Infection and Immunity.
[41] Anders Folkesson,et al. Evolutionary dynamics of bacteria in a human host environment , 2011, Proceedings of the National Academy of Sciences.
[42] I. Sá-Correia,et al. Quantitative proteomics (2‐D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy , 2011, Proteomics.
[43] J. Curtis,et al. Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.
[44] S. McKeon,et al. Functional quorum sensing systems are maintained during chronic Burkholderia cepacia complex infections in patients with cystic fibrosis. , 2011, The Journal of infectious diseases.
[45] R. Proctor,et al. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection , 2011, EMBO molecular medicine.
[46] A. Fodor,et al. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis , 2011, Thorax.
[47] S. McColley,et al. Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis , 2011, Clinical Microbiology Reviews.
[48] J. Gilsdorf,et al. Molecular Basis of Increased Serum Resistance among Pulmonary Isolates of Non-typeable Haemophilus influenzae , 2011, PLoS pathogens.
[49] R. Brant,et al. Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections. , 2011, American journal of respiratory and critical care medicine.
[50] A. Oliver. Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy. , 2010, International journal of medical microbiology : IJMM.
[51] J. Heesemann,et al. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. , 2010, International journal of medical microbiology : IJMM.
[52] Gordon Ramage,et al. Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. , 2010, FEMS microbiology letters.
[53] L. Nicod,et al. [Pseudomonas aeruginosa in chronic obstructive pulmonary disease]. , 2010, Revue medicale suisse.
[54] T. Welte,et al. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options. , 2010, International journal of antimicrobial agents.
[55] D. Viemann,et al. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. , 2010, The Journal of infectious diseases.
[56] D. Speert,et al. The role of mucoidy in virulence of bacteria from the Burkholderia cepacia complex: a systematic proteomic and transcriptomic analysis. , 2010, The Journal of infectious diseases.
[57] Jason A. Papin,et al. Metabolic Network Analysis of Pseudomonas aeruginosa during Chronic Cystic Fibrosis Lung Infection , 2010, Journal of bacteriology.
[58] M. Valvano,et al. A Decade of Burkholderia cenocepacia Virulence Determinant Research , 2010, Infection and Immunity.
[59] Eoin L. Brodie,et al. Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients , 2010, PloS one.
[60] J. Fothergill,et al. Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations. , 2010, Journal of medical microbiology.
[61] Lior Pachter,et al. Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.
[62] B. Tümmler,et al. Pseudomonas aeruginosa population biology in chronic obstructive pulmonary disease. , 2009, The Journal of infectious diseases.
[63] S. Nseir,et al. Management of invasive aspergillosis in patients with COPD: Rational use of voriconazole , 2009, International journal of chronic obstructive pulmonary disease.
[64] T. Voyno-Yasenetskaya,et al. Lipopolysaccharide Stimulates Platelet Secretion and Potentiates Platelet Aggregation via TLR4/MyD88 and the cGMP-Dependent Protein Kinase Pathway1 , 2009, The Journal of Immunology.
[65] B. Rubin. Mucus, phlegm, and sputum in cystic fibrosis. , 2009, Respiratory care.
[66] Matthew R. Parsek,et al. Pseudomonas aeruginosa Rugose Small-Colony Variants Have Adaptations That Likely Promote Persistence in the Cystic Fibrosis Lung , 2009, Journal of bacteriology.
[67] P. François,et al. CodY in Staphylococcus aureus: a Regulatory Link between Metabolism and Virulence Gene Expression , 2009, Journal of bacteriology.
[68] G. Amoutzias,et al. Role of siderophores in cystic fibrosis pathogenesis: foes or friends? , 2009, International journal of medical microbiology : IJMM.
[69] S. Molin,et al. Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host–pathogen interactions in cystic fibrosis , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[70] M. Maciá,et al. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[71] S. Quirce,et al. Aspergillus fumigatus y Candida albicans en la fibrosis quística: significado clínico e inmunorrespuestas séricas específicas de inmunoglobulinas G, A y M , 2008 .
[72] L. M. Moreira,et al. Differential Mucoid Exopolysaccharide Production by Members of the Burkholderia cepacia Complex , 2008, Journal of Clinical Microbiology.
[73] A. H. Wang,et al. Discovery of virulence factors of pathogenic bacteria. , 2008, Current opinion in chemical biology.
[74] S. Quirce,et al. [Aspergillus fumigatus and Candida albicans in cystic fibrosis: clinical significance and specific immune response involving serum immunoglobulins G, A, and M]. , 2008, Archivos de bronconeumologia.
[75] Steve P. Bernier,et al. A LysR-Type Transcriptional Regulator in Burkholderia cenocepacia Influences Colony Morphology and Virulence , 2007, Infection and Immunity.
[76] M. Parsek,et al. Pseudomonas aeruginosa Psl Is a Galactose- and Mannose-Rich Exopolysaccharide , 2007, Journal of bacteriology.
[77] F. Zanetti,et al. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[78] David A. D'Argenio,et al. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients , 2007, Molecular microbiology.
[79] S. Levy,et al. Molecular Mechanisms of Antibacterial Multidrug Resistance , 2007, Cell.
[80] S. Johnston,et al. The role of antibiotics in asthma , 2007, International Journal of Antimicrobial Agents.
[81] F. Blasi,et al. Antibiotic therapy and prophylaxis in COPD , 2007 .
[82] J. Shiloach,et al. A perspective on microarrays: current applications, pitfalls, and potential uses , 2007, Microbial cell factories.
[83] R. Boucher,et al. Evidence for airway surface dehydration as the initiating event in CF airway disease , 2007, Journal of internal medicine.
[84] D. Speert,et al. Proteomic identification and characterization of bacterial factors associated with Burkholderia cenocepacia survival in a murine host. , 2007, Microbiology.
[85] J. Heesemann,et al. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. , 2007, The Journal of infectious diseases.
[86] L. Saiman,et al. Antimicrobial Susceptibility and Synergy Studies of Burkholderia cepacia Complex Isolated from Patients with Cystic Fibrosis , 2006, Antimicrobial Agents and Chemotherapy.
[87] Pradeep K. Singh,et al. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[88] David A. D'Argenio,et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[89] M. Otto,et al. Staphylococcus quorum sensing in biofilm formation and infection. , 2006, International journal of medical microbiology : IJMM.
[90] A. S. Lynch. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view. , 2006, Biochemical pharmacology.
[91] R. Ernst,et al. Exopolysaccharides from Burkholderia cenocepacia Inhibit Neutrophil Chemotaxis and Scavenge Reactive Oxygen Species* , 2006, Journal of Biological Chemistry.
[92] M. Denton,et al. Staphylococcus aureus and MRSA , 2006 .
[93] A. Alanis,et al. Resistance to antibiotics: are we in the post-antibiotic era? , 2005, Archives of medical research.
[94] Matthew R. Parsek,et al. Characterization of Colony Morphology Variants Isolated from Pseudomonas aeruginosa Biofilms , 2005, Applied and Environmental Microbiology.
[95] B. Grant,et al. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. , 2005, American journal of respiratory and critical care medicine.
[96] F. Pattus,et al. The Crystal Structure of the Pyoverdine Outer Membrane Receptor FpvA from Pseudomonas aeruginosa at 3.6 Å Resolution , 2005 .
[97] M. Freeman,et al. Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury , 2005, Infection and Immunity.
[98] S. Rennard,et al. Pathogenesis of COPD. , 2003, Clinical cornerstone.
[99] F. Pattus,et al. The crystal structure of the pyoverdine outer membrane receptor FpvA from Pseudomonas aeruginosa at 3.6 angstroms resolution. , 2005, Journal of molecular biology.
[100] C. Wolz,et al. Regulatory and genomic plasticity of Staphylococcus aureus during persistent colonization and infection. , 2004, International journal of medical microbiology : IJMM.
[101] Michael E. Watson,et al. Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. , 2004, Microbiology.
[102] J. Buer,et al. Expression Analysis of a Highly Adherent and Cytotoxic Small Colony Variant of Pseudomonas aeruginosa Isolated from a Lung of a Patient with Cystic Fibrosis , 2004, Journal of bacteriology.
[103] S. Majumdar,et al. Importance of the Ornibactin and Pyochelin Siderophore Transport Systems in Burkholderia cenocepacia Lung Infections , 2004, Infection and Immunity.
[104] Herbert Schmidt,et al. Pathogenicity Islands in Bacterial Pathogenesis , 2004, Clinical Microbiology Reviews.
[105] S. Häussler,et al. Evaluation of the Merlin, Micronaut System for Automated Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa and Burkholderia Species Isolated from Cystic Fibrosis Patients , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[106] S. M. Kirov. Bacteria that express lateral flagella enable dissection of the multifunctional roles of flagella in pathogenesis. , 2003, FEMS microbiology letters.
[107] P. Vandamme,et al. Fatal Outcome of Lung Transplantation in Cystic Fibrosis Patients due to Small-Colony Variants of the Burkholderia cepacia Complex , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[108] J. Bargon,et al. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis , 2003, Mycoses.
[109] T. Beveridge,et al. Colonial Morphology of Burkholderia cepacia Complex Genomovar III: Implications in Exopolysaccharide Production, Pilus Expression, and Persistence in the Mouse , 2003, Infection and Immunity.
[110] H. Sahl,et al. Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. , 2003, International journal of medical microbiology : IJMM.
[111] J. Musser,et al. Evolutionary genomics of pathogenic bacteria. , 2001, Trends in microbiology.
[112] D. Metze,et al. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[113] K. Mathee,et al. Posttranslational control of the algT (algU)-encoded sigma22 for expression of the alginate regulon in Pseudomonas aeruginosa and localization of its antagonist proteins MucA and MucB (AlgN) , 1997, Journal of bacteriology.
[114] R. Proctor,et al. Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. , 1997, The Journal of antimicrobial chemotherapy.
[115] V. Deretic,et al. Microbial pathogenesis in cystic fibrosis: co‐ordinate regulation of heat‐shock response and conversion to mucoidy in Pseudomonas aeruginosa , 1997, Molecular microbiology.
[116] V. Deretic,et al. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. , 1996, Microbiological reviews.
[117] V. Deretic,et al. Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis , 1996, Journal of bacteriology.
[118] R. Proctor,et al. Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. , 1994, The Journal of infectious diseases.
[119] E. Mahenthiralingam,et al. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis , 1994, Infection and immunity.
[120] D. Martin,et al. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[121] P. Libby,et al. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS , 1990, Infection and immunity.
[122] Y. Ogawa,et al. Involvement of central action of lipopolysaccharide in pyrogen fever. , 1984, Japanese journal of pharmacology.
[123] R. Hancock,et al. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains , 1983, Infection and immunity.
[124] R. Jones,et al. A new polysaccharide resembling alginic acid isolated from pseudomonads. , 1966, The Journal of biological chemistry.